Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025BloodOpen Access

Rising mortality trends in elderly multiple myeloma patients with hypertension: A CDC wonder database analysis (1999–2023)

View Full Paper
Ask AI
Bookmark
Share

Authors

RIRehan IshaqueATAbdul Subhan TalpurFTFawad Talat

Discussion

Loading...

Member takes

Overview

Analysis reveals rising mortality rates in elderly with multiple myeloma and hypertension, indicating healthcare disparities.

Key Points

  • Mortality rates for hypertension-related multiple myeloma increased significantly among elderly individuals, emphasizing urgent healthcare needs.
  • Data showed a rising trend in mortality rates from 1999 to 2023, with marked increases in African American populations.
  • Analysis using ICD-10 classification revealed disparities across urban and rural populations influencing mortality outcomes.
  • Study highlights the need for improved access to treatments like Autologous Stem Cell Transplantation for affected patients.

Cite This Study

Ishaque et al. (2025) studied this question.

synapsesocial.com/papers/69362f574fa91c937236da6dhttps://doi.org/10.1182/blood-2025-2793
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Racial, geographic, and gender disparities in ischemic heart disease mortality in patients with multiple myeloma: A nationwide analysis (1999–2023).2025
  2. 2Trends in death from multiple myeloma with concomitant diabetes mellitus in the USA2025
  3. 3Temporal trends and demographic patterns in multiple myeloma incidence in the United States: a 24-year analysis of the CDC WONDER database (1999–2022)2026
  4. 4Trends in mortality from multiple myeloma in patients younger than 55 years of age in the United States: A retrospective analysis from 1999 to 20202025
  5. 5National trends in sepsis-specific mortality among adults in the United States with multiple myeloma, a 24-year analysis2025